NTLA — Intellia Therapeutics, Inc. stock price, charts and financials

QT20Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. (NASDAQ: NTLA) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
11.32
+0.55+5.11%
OverviewShort InterestFilings
NTLAQT20Intellia Therapeutics, Inc.·NASDAQ
11.32+5.11%
TA
Loading chart...
Short Interest History· Twice monthly
Settlement DateShort InterestAvg Daily VolumeShares FloatShort Float %Short Ratio
Jul-15-2645.78M6.82M106.24M43.09%6.71
Jun-30-2649.22M6.49M106.24M46.33%7.58
Jun-15-2650.32M6.01M106.24M47.36%8.38
May-29-2648.52M5.70M106.24M45.66%8.51
May-15-2651.85M5.34M106.24M48.80%9.71
Apr-30-2643.53M4.83M106.24M40.97%9.01
Apr-15-2638.81M4.39M106.24M36.53%8.84
Mar-31-2638.95M4.80M106.24M36.66%8.11
Mar-13-2639.44M4.73M106.24M37.12%8.34
Feb-27-2644.31M4.53M106.24M41.70%9.78
Feb-13-2645.26M4.97M106.24M42.60%9.11
Jan-30-2645.32M6.10M106.24M42.66%7.42